Clive A. Meanwell
Independent DirectorDr. Clive A. Meanwell, M.D., MB, ChB, Ph.D, is Co-Founder, Co-CEO & Director of Corsera Health, Inc. Dr. Meanwell Co-Founded Metsera Inc. and served as its Director since June 2022 until November 13, 2025 and served as Chief Executive Officer since March 2023 until September 27, 2024. Dr. Meanwell served as Executive Chairman at Metsera, Inc. until November 13, 2025. since September 27, 2024. Dr. Meanwell serves as Managing Director, Chairman and Managing Partner at Population Health Partners. He served as Director at Invivyd, Inc. (formerly known as Adagio Therapeutics, Inc.) since June 22, 2022 until May 21, 2024. He serves as Director at Saama Technologies, Inc. since November 2021. He is a Co-Founder of Population Health Investment Co., Inc. and has been its Chief Executive Officer since September 2020 and serves as its Director. Dr. Meanwell serves as an Independent Director at Fractyl Health, Inc since June 2021. Dr. Meanwell had been an Independent Director of EQRx, Inc. (Former Name: CM Life Sciences III Inc.) since October 2020 until July 31, 2023. He was the Director of Comanche Biopharma Corp. He serves as Executive Chairman and Founder of Population Health Partners since May 2020. He served as Chief Executive Officer of The Medicines Company since August 2004 until December 11, 2018 and served as its Chief Innovation Officer since December 11, 2018 until 2020. Dr. Meanwell served as President of the firm since October 2009 and served as its Chief Executive Officer from August 2004 to December 2004 and served as Co-Chief Executive Officer and President from 1996 to September 2001. Dr. Meanwell served as the President of Targanta Therapeutics Corp. since February 25, 2009. He worked at Applied Molecular Evolution, Inc. From 1995 to 1996, he was a Founding Partner and Managing Director at MPM Capital. From 1986 to 1995, Dr. Meanwell held various positions at Hoffmann-La Roche Inc. including Senior Vice President from 1992 to 1995, Vice President from 1991 to 1992 and Director of Product Development from 1986 to 1991. He served as the Chairman of The Medicines Company from September 2001 to August 31, 2015. Dr. Meanwell is the Vice Chairman of BB Biotech. Dr. Meanwell is a Founding Partner of Population Health Partners. He was a Founder of The Medicines Company and served as its Director from July 1996 to January 6, 2020. He served as a Director of Applied Molecular Evolution, Inc. He served as the Executive Chairman of Medicines Company from September 2001 to August 2004. He has been Director of Endo Pharmaceuticals Solutions Inc. since January 2003. He serves as a Director of Hoffmann-La Roche Limited. He served as a Director of BioNJ Inc. from 2018 to February 2019. He served as a Director of Targanta Therapeutics Corp. since February 25, 2009 and Endo Pharmaceuticals Holdings Inc. from 2003 to May 27, 2010. Prior to December 2018, he served as The Medicine Company's Chief Executive Officer since February 2012, The Medicine Company's Chief Executive Officer and President from October 2009 to February 2012, The Medicine Company's Chief Executive Officer from August 2004 to October 2009, as The Medicine Company's President from August 2004 to December 2004, The Medicine Company's executive Chairman from September 2001 to August 2004 and The Medicine Company's Chief Executive Officer and President from 1996 to September 2001. He worked in the Department of Medicine at The Queen Elizabeth Medical Center and associated hospitals. He served as Director of Scientific and Development Advisory Board of Maxim Pharmaceuticals Inc. since February 6, 2003. Dr. Meanwell holds an M.D., MB ChB and a Ph.D. from the University of Birmingham, United Kingdom, where he also trained in Medical Oncologya.
Positions
- Company NameFractyl Health, Inc.Stock CodeGUTSPositionIndependent DirectorColleagues
- HRHarith RajagopalanCo-Founder, President, CEO, Director & Principal Executive Officer
- AGAjay Gopal RoyanIndependent Chairman
- SSSarah S. ToomeyGeneral Counsel & Corporate Secretary
- LSLara Smith WeberCFO & Treasurer
- BLBrian LuqueHead of Investor Relations & Corporate Development
- JFJon FitzgeraldSenior Vice President of Regulatory, Quality & Clinical
- WWWilliam Warren BradleyIndependent Director
- KBKelly BarnesIndependent Director
